New injection shows promise for bulging eyes condition
NCT ID NCT06625411
Summary
This study is testing whether regular injections of an experimental drug called VRDN-003 can help people with active Thyroid Eye Disease. About 117 participants will receive either the drug or a placebo injection every 4 or 8 weeks to see if it reduces eye bulging, inflammation, and double vision. The trial is double-masked, meaning neither participants nor doctors know who gets the real treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID EYE DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
A.P.J. Office
Newport Beach, California, 92660, United States
-
Advancing Research International, LLC
Los Angeles, California, 90023, United States
-
Agile Clinical Research Trials, LLC
Atlanta, Georgia, 30328, United States
-
Alliance Research Institute - Canoga Park
Canoga Park, California, 91304, United States
-
Alliance Research Institute - Lynwood
Lynwood, California, 90262, United States
-
Anmed Health Services LLC
Miami, Florida, 33193, United States
-
Asheville Clinical Research
Asheville, North Carolina, 28803, United States
-
Baylor College of Medicine/Alkek Eye Center
Houston, Texas, 77030, United States
-
Byers Eye Institute at Stanford University
Palo Alto, California, 94303, United States
-
C&A Clinical Trials Corp
Cape Coral, Florida, 33990, United States
-
Continental Clinical Research
Miami, Florida, 33144, United States
-
Duke Eye Center
Durham, North Carolina, 27705, United States
-
Fraser Eye Care Center
Fraser, Michigan, 48026, United States
-
Gulf Coast Clinical Trials
Houston, Texas, 77070, United States
-
Hype Clinical Research LLC
Miami, Florida, 33145, United States
-
Ilumina Medical Research
Kissimmee, Florida, 34744, United States
-
Kahana Oculoplastic & Orbital Surgery
Livonia, Michigan, 48152, United States
-
Marvel Clinical Research
Huntington Beach, California, 92647, United States
-
Med-Care Research
Miami, Florida, 33125, United States
-
Neuro-Eye Clinical Trials
Houston, Texas, 77074, United States
-
Opthalmic Consultants of Boston
East Weymouth, Massachusetts, 02189, United States
-
Pasadena Clinical Trials
Pasadena, California, 91101, United States
-
Roski Eye Institute, Keck School of Medicine, USC
Los Angeles, California, 90033, United States
-
Rutgers New Jersey Medical School
Newark, New Jersey, 07103, United States
-
S.L. Office
Las Vegas, Nevada, 89144, United States
-
Sarasota Retina Institute
Sarasota, Florida, 34239, United States
-
Scottsdale Clinical Trials
Scottsdale, Arizona, 85260, United States
-
Senta Clinic
San Diego, California, 92108, United States
-
United Medical Research Institute
Inglewood, California, 90301, United States
-
University Health
Kansas City, Missouri, 64108, United States
-
University of Washington, Eye institute
Seattle, Washington, 98104, United States
-
Vector Clinical Trials
Sparks, Nevada, 89436, United States
-
Vision Medical Research
Orland Park, Illinois, 60462, United States
-
West Virginia University Eye Institute
Morgantown, West Virginia, 26506, United States
Conditions
Explore the condition pages connected to this study.